NICE issued advice last week on the fracture prevention treatment denosumab, the diabetes drug...The institute backed denosumab (Prolia) for some postmenopausal women at increased risk of osteoporotic fractures if other NHS treatments are unsuitable.
NICE has also issued final guidance approving the use of the drug liraglutide for some diabetes patients. PCTs must now fund the drug for eligible ...
by PCTs. These include drugs for cardiovascular and GI disorders, asthma and diabetes.
Of 71 PCTs ...
chairman Dr Nigel Capps.
Gavin Terry, policy manager at Diabetes UK, said patients' health must ...
and rabeprazole.
Others: asthma (ciclesonide), diabetes (vildagliptin), drug misuse (methadone, some doses ...
Brian Karet, RCGP clinical lead for diabetes, said GP commissioners would soon have to make decisions ...
24 Mar 2011
| by Professor Ruth Chambers
/80mmHg in patients with diabetes or with ACR 30mg/mmol. And the practice protocol for CKD should specify ...
.
Check that all your practice protocols for review of patients with common LTCs (diabetes, asthma, COPD ...
of ezetimibe and high-cost statins in line with NICE guidance.
Type 2 diabetes - Consider risks ...
07 Jul 2011
| by Georgina Craig
MEDICINE SERVICE
Engagement
Target conditions: asthma and COPD, type-2 diabetes ...
11 Nov 2010
| by Professor John Geddes
of cardiovascular disease, diabetes mellitus and thyroid disease. 3
Other mental disorders ...